Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.7912
-0.0062 (-0.78%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7820
-0.0092 (-1.16%)
After-hours: Mar 16, 2026, 7:39 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $6.9 million as of March 16, 2026. Its market cap has decreased by -29.53% in one year.
Market Cap
6.90M
Enterprise Value
-3.86M
1-Year Change
-29.53%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $6.90M, a decrease of -75.38%. That is a compound annual growth rate of -7.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 7.32M | -10.88% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 7.51M |
| CollPlant Biotechnologies | 7.47M |
| Moolec Science | 7.43M |
| Alaunos Therapeutics | 7.37M |
| SciSparc | 7.07M |
| Dogwood Therapeutics | 7.02M |
| PharmaCyte Biotech | 6.99M |
| Mustang Bio | 6.88M |